Workflow
25华邦EB可交换公司债券
icon
Search documents
华邦生命健康股份有限公司 关于可交换公司债券换股完成暨摘牌的公告
Group 1 - The company, Huabang Life Health Co., Ltd., announced a non-public issuance of exchangeable bonds aimed at professional investors, with a total issuance size of 600 million RMB and a term of 3 years [2] - The exchangeable bonds, referred to as "25 Huabang EB," have been fully converted, resulting in a total of 0 bonds remaining, and will be delisted from the Shenzhen Stock Exchange on December 8, 2025 [3] - Following the completion of the bond conversion, the company holds 126,755,153 shares of Kaisheng New Materials Co., Ltd., representing 30.13% of its total share capital, without affecting its status as the controlling shareholder [4]
华邦生命健康股份有限公司关于可交换公司债券换股完成暨摘牌的公告
Group 1 - The company has completed the exchange of its convertible bonds, with a total of 0 bonds remaining, and these bonds will be delisted from the Shenzhen Stock Exchange on December 8, 2025 [3] - The company issued a total of 600 million RMB in convertible bonds, with a maturity of 3 years, aimed at professional investors [2] - After the completion of the bond exchange, the company holds 126,755,153 shares of Kaisheng New Materials, accounting for 30.13% of its total share capital, maintaining its status as the controlling shareholder [4] Group 2 - The company received a no-objection letter from the Shenzhen Stock Exchange confirming that the issuance of the convertible bonds complies with the listing conditions [2] - The bonds were issued on April 22, 2025, following the announcement made on December 11, 2024, regarding the non-public issuance [2] - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1]
山东凯盛新材料股份有限公司 关于控股股东非公开发行可交换公司债券进入 换股期的提示性公告
本公司及董事会全体成员保证公告内容真实、准确和完整,并对公告中的虚假记载、误导性陈述或者重 大遗漏承担责任。 山东凯盛新材料股份有限公司(以下简称"公司"或"本公司")近日收到公司控股股东华邦生命健康股份 有限公司(以下简称"华邦健康")的书面通知,华邦健康面向专业投资者非公开发行可交换公司债券将 进入换股期。具体情况如下: 一、控股股东可交换公司债券的基本情况 华邦健康于2025年4月22日面向专业投资者非公开发行可交换公司债券(以下简称"本期可交换债 券"),并于2025年4月28日起在深圳证券交易所挂牌交易,债券简称"25华邦EB",债券代码"117227", 发行规模6亿元,期限3年,初始换股价格为14.88元/股。 2025年4月30日,因公司实施2024年度权益分派,"25华邦EB"的换股价格由14.88元/股调整为14.83元/ 股。 二、控股股东可交换公司债券进入换股期的情况 登录新浪财经APP 搜索【信披】查看更多考评等级 董事会 2025年10月21日 三、其他情况说明及相关风险提示 截至本公告披露日,华邦健康持有本公司股份167,216,000股(其中包括预备用于交换的股票数量为 60, ...